Articles from Biotech Business (August 1, 2008)

1-5 out of 5 article(s)

Title	Type	Words
APP PHARMACEUTICALS GETS APPROVALS FOR ADDITIONAL DOSAGES.		265
BAYER EXPANDS HEMOPHILIA PORTFOLIO FEATURING MAXY-VII.	Company overview	943
HANA BIOSCIENCES GETS U.S.ORPHAN DRUG DESIGNATION FOR MARQIBO.		664
REGENERX COMPLETES ENROLLMENT OF PHASE IA FOR HEART DRUG.		550
SENESCO CHOOSES VGXI TO PRODUCE FACTOR 5A PLASMID.		444

Publications by Name	Publications by Date	Authors	Literature
A-D E-O P-T U-Z	17 74 75 78 80 82 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09 10	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z	A B C D E F G H I J K L M N O P Q R S T U V W X Y Z